Active Pharmaceutical Ingredients (APIs)
Sub-Segment: Excipients
Excipients play a crucial role in drug formulation, aiding in the delivery, stability, and bioavailability of active pharmaceutical ingredients (APIs). Among the various excipients used in pharmaceutical formulations, pharmaceutical grade lactose is extensively employed. Lactose-based excipients, such as lactose monohydrate and lactose anhydrous, are commonly used as fillers, diluents, and stabilizers in tablet and capsule formulations. Their high compatibility with various APIs, excellent flow properties, and low hygroscopicity make them ideal excipients in pharmaceutical manufacturing.
The pharmaceutical grade lactose market is witnessing significant growth within the excipients sub-segment due to the rising demand for solid oral dosage forms and advancements in drug delivery systems. The ease of processing, cost-effectiveness, and availability of pharmaceutical grade lactose in various particle sizes make it a preferred excipient choice for formulators. Moreover, the increasing focus on patient-centric drug formulations, such as orally disintegrating tablets and modified-release formulations, further boosts the demand for lactose-based excipients.
The pharmaceutical grade lactose market exhibits a competitive landscape with the presence of several key players striving to gain a larger market share. These market players are adopting strategies such as mergers and acquisitions, collaborations, and product launches to strengthen their foothold in the market. They are also increasingly focusing on expanding their product portfolios and enhancing their manufacturing capabilities.
Some of the prominent market players operating in the pharmaceutical grade lactose market include Meggle Pharma, DuPont de Nemours, Inc., Armor Pharma, Kerry Inc., BASF SE, MEGGLE Excipients & Technology, Biopraxis, ALIMENTALIS, DFE Pharma, and Merck KGaA. These companies are investing in research and development activities and are constantly innovating to cater to the evolving needs of the pharmaceutical industry.